Vaccination Program
OtherDesign & implement a program for Ob/Gyns to vaccinate women against human papillomavirus, influenza, & pertussis
NCT Number: NCT00828555
PURPOSE To develop, implement, and evaluate the effectiveness of a program designed to assist community Ob/Gyns in vaccinating adolescent and adult women against vaccine-preventable diseases.
SPECIFIC AIMS
1. Determine the feasibility of implementing a successful vaccination program for adolescent and adult women in Ob/Gyn offices by direct assessment of medical personnel & office staff on their:
* Attitudes towards vaccination of women against preventable diseases * Perceived barriers to implementing a program to vaccinate women in their offices * Ideas on how to overcome barriers to successful program implementation * Current vaccination practices and office-specific administrative processes 2. Design & implement a program for Ob/Gyns to vaccinate women against human papillomavirus, influenza, & pertussis 3. Determine the effectiveness of the vaccination program based on
* Pre- and post-program vaccination rates * Program satisfaction amongst Ob/Gyn providers and office staff * Willingness to continue and possibly extend the program to additional vaccines 4. Quantify the level of support and resources needed to develop and implement the vaccination program
Looking for future studies?
Notify Me12 year–26 year
Female
Observational
Westside OBGYN, Burlington, North Carolina, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Design & implement a program for Ob/Gyns to vaccinate women against human papillomavirus, influenza, & pertussis
Time frame: Full-scale program implementation will cover a 12 month period, tentatively planned to begin in April 2009.
Duke University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07710586
Infections, Influenza Vaccine
Dongtai, Jiangsu, China
View Trial DetailsNCT07332689
Infections, Influenza Vaccine
Lanzhou, Gansu, China
View Trial DetailsNCT01687517
Hemic and Lymphatic Diseases, Hypersensitivity
Paris, France
View Trial DetailsNCT06646406
COVID-19 Immunisation, Infections
Rochester, Minnesota, United States
View Trial Details